Data Availability
This article has no associated data.
References
Hasan SS, Kow CS, Verma RK, Ahmed SI, Mittal P, Chong DWK. An evaluation of medication appropriateness and frailty among residents of aged care homes in Malaysia: a cross-sectional study. Medicine (Baltimore). 2017;96(35): e7929.
Thiruchelvam K, Wong PS, Kairuz T, Babar ZUD, Hasan SS. Consolidated medication review algorithm to improve medications use in older adults: components, scoring scheme, and implementation. J Am Med Dir Assoc. 2018;19(8):717–8.
Thiruchelvam K, Byles J, Hasan SS, Egan N, Kairuz T. Prevalence and association of continuous polypharmacy and frailty among older women: a longitudinal analysis over 15 years. Maturitas. 2021;146:18–25.
Trevisan C, Haxhiaj L, Malara A, et al. Polypharmacy and antibody response to SARS-CoV-2 vaccination in residents of long-term care facilities: the GeroCovid Vax Study [published online ahead of print, 2023 Nov 8]. Drugs Aging. 2023. https://doi.org/10.1007/s40266-023-01075-9.
Thiruchelvam K, Byles J, Hasan SS, Egan N, Cavenagh D, Kairuz T. Common combinations of medications used among oldest-old women: a population-based study over 15 years. Aging Clin Exp Res. 2021;33(7):1919–28.
Thiruchelvam K, Byles J, Hasan SS, Egan N, Kairuz T. Frailty and potentially inappropriate medications using the 2019 Beers Criteria: findings from the Australian Longitudinal Study on Women’s Health (ALSWH). Aging Clin Exp Res. 2021;33(9):2499–509.
Thiruchelvam K, Byles J, Hasan SS, Egan N, Kairuz T. Residential medication management reviews and continuous polypharmacy among older Australian women. Int J Clin Pharm. 2021;43(6):1619–29.
Lafleur BJ, White L, Dake MD, Nikolich JZ, Sprissler R, Bhattacharya D. No evidence that analgesic use after COVID-19 vaccination negatively impacts antibody responses. Immunohorizons. 2023;7(12):834–41.
Chung H, Campitelli MA, Buchan SA, et al. Evaluating the impact of statin use on influenza vaccine effectiveness and influenza infection in older adults. Clin Infect Dis. 2023;77(2):303–11.
Funding
No funding was received for publishing this article.
Author information
Authors and Affiliations
Contributions
All authors contributed equally to this article.
Corresponding author
Ethics declarations
Conflicts of Interest
The authors have no competing interests to declare that are relevant to the content of this article.
Rights and permissions
About this article
Cite this article
Kow, C.S., Ramachandram, D.S., Hasan, S.S. et al. Comment on: “Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: the GeroCovid Study”. Drugs Aging 41, 283–285 (2024). https://doi.org/10.1007/s40266-024-01106-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-024-01106-z